The therapeutic use of anti-TNF monoclonal antibodies, such as the TNF inhibitor, etanercept, is currently approved for the treatment of autoimmune diseases, such as Crohn’s disease and rheumatoid arthritis. Here, TNF is linked to Crohn disease.